Navigation Links
InvivoSciences receives NIH grant for heart technology

Wauwatosa, Wis. - To perfect a technology that allows researchers to test new drugs on tiny rings of beating heart tissue, one needs money. And fortunately for one local company, the federal government is willing to absorb some of the cost of such an endeavor.

To improve its technology, InvivoSciences, LLC, a start-up biotechnology firm ......

Full article >>> or," was developed in collaboration with Middleton-based Gilson, Inc. It detects drug interactions with tissue that mimics healthy or diseased hearts. With this capability, some researchers could eliminate the need to test drugs on whole animals.

......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 10/27/06


Related biology technology :

1. Medical College receives $377K to study brain disease
2. Lucigen receives $750K grant to boost biofuel yields
3. Medical College receives $1.4M cancer grant
4. Wisconsin biotech firm receives $107K NIH grant
5. Medical College receives $11 million grant to study high blood pressure
6. Madison business receives $115,000 of new state biofuels funding
7. Superior receives funds for technical training
8. UWM receives state funding for plastics research
9. GEs Centricity EHR receives federal certification
10. WHIE receives state eHealth Initiative contract
11. SGI receives court approval for bankruptcy motions
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/17/2017)... ... February 17, 2017 , ... Academy of Model Aeronautics ... leading maker of unmanned aircraft systems (UAS), are launching a joint program to ... effectively, and support educational outreach efforts. , AMA and DJI will collaborate on ...
(Date:2/16/2017)... (PRWEB) , ... February 16, 2017 , ... Avomeen & ... The event will be held at Avomeen Analytical Services (4840 Venture Dr., Ann ... MichBio member organization. They provide an opportunity to interact with peers, make new connections ...
(Date:2/16/2017)... , Feb. 16, 2017  MDNA Life Sciences ... development of liquid biopsy tests based on the ... an exclusive license agreement with its first international ... liquid biopsy test for prostate cancer, the Prostate ... . This is the first overseas appointment ...
(Date:2/16/2017)... 16, 2017   Capricor Therapeutics, Inc. ... company developing first-in-class biological therapies for cardiac and ... elected to terminate its license agreement with the ... including Cenderitide. "Our decision to return ... prioritize our efforts to advance our core cell ...
Breaking Biology Technology:
(Date:2/3/2017)... ANTONIO , Feb. 3, 2017  Texas Biomedical Research ... Dr. Larry Schlesinger as the Institute,s new ... Texas Biomed effective May 31, 2017. He is currently the ... Director of the Center for Microbial Interface Biology at Ohio ... Schlesinger as the new President and CEO of Texas Biomed," ...
(Date:2/2/2017)... , Feb. 2, 2017   TapImmune, ... clinical-stage immuno-oncology company specializing in the development of ... the treatment of cancer and metastatic disease, announced ... and GMP manufacturing of a second clinical lot ... targeting folate receptor alpha. The manufactured vaccine product ...
(Date:2/2/2017)... -- Central to its deep commitment to honor the ... Prize Foundation today announced the laureates of the ... in their respective fields of Life Sciences and ... recognized with the 2017 Japan Prize for original ... the advancement of science and technology, but also ...
Breaking Biology News(10 mins):